The Expander-2 trial randomly assigned men with BPH symptoms at 23 sites in the US and Canada to receive a temporary nitinol urethral implant, Urocross Expander, or a sham procedure.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results